Sebastian Felgner

Title: Sebastian Felgner: Innovator in Immunogenic Compositions

Introduction

Sebastian Felgner is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of immunology, particularly through his innovative work on immunogenic compositions.

Latest Patents

Sebastian Felgner holds one patent related to an immunogenic composition. This invention involves a mutated strain that includes mutations in flagellin II genes, such as the fliF gene, and additional genes like aroA, IpxR, pagP, pagL, ydiV, and optionally eptA and arnT. The patent also describes immunogenic compositions that may include a pharmaceutically accepted carrier, diluent, or effluent. Furthermore, it outlines a method for producing outer membrane vesicles by cultivating the strain and isolating the vesicles. The invention provides bacteria or outer membrane vesicles that can be used as a transport moiety or as part of an immunogenic composition, such as a vaccine or immunotherapy platform, particularly for the therapeutic treatment of cancer.

Career Highlights

Sebastian Felgner is associated with Helmholtz-Zentrum für Infektionsforschung GmbH, where he continues to advance research in infectious diseases and immunology. His work has the potential to impact therapeutic strategies significantly.

Collaborations

Sebastian has collaborated with notable colleagues, including Marc Erhardt and Dino Kocijancic, contributing to a dynamic research environment focused on innovative solutions in immunology.

Conclusion

Sebastian Felgner's contributions to immunogenic compositions and his innovative approach to vaccine development highlight his role as a key figure in the field of immunology. His work continues to pave the way for advancements in therapeutic treatments for cancer and infectious diseases.